Journal List > Korean J Urol > v.50(8) > 1005385

Shim, Yoo, Jeong, and Kim: The Preoperative Factors Predicting a Positive Frozen Section during Radical Prostatectomy for Prostate Cancer

Abstract

Purpose

The purpose of this study was to identify the preoperative factors that predict a positive frozen section during radical prostatectomy for prostate cancer.

Materials and Methods

We retrospectively analyzed preoperative prostate-specific antigen (PSA), prostate volume, Gleason score, the number or percent (%) of cancer-positive cores from prostate biopsy, and the clinical stage of 364 patients who underwent radical prostatectomy between 1993 and 2007. We compared these parameters between patients who had positive frozen sections in specimens from the urethra or bladder neck with those who had negative frozen sections.

Results

The PSA and Gleason score were significantly higher and prostate volume was significantly smaller in patients with positive frozen sections in the urethra than in patients with negative frozen sections. The results were the same for the bladder neck. In multivariate analysis, PSA was the only independent predictor for positive frozen sections at the bladder neck, and the cutoff value was 8.71 ng/ml.

Conclusions

Preoperative PSA may be a potent factor for predicting positive frozen sections during radical prostatectomy, especially in the bladder neck. Therefore, it may be beneficial to prepare frozen sections of the bladder neck during the operation to reduce the positive resection margin when PSA is higher than 8.7 ng/ml.

REFERENCES

1. Lepor H, Kaci L. Role of intraoperative biopsies during radical retropubic prostatectomy. Urology. 2004; 63:499–502.
crossref
2. Shah O, Melamed J, Lepor H. Analysis of apical soft tissue margins during radical retropubic prostatectomy. J Urol. 2001; 165:1943–8.
crossref
3. Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M. Positive surgical margins after radical prostatectomy: Do they have an impact on biochemical or clinical progression? BJU Int. 2008; 102:1413–8.
crossref
4. Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 2005; 174:903–7.
crossref
5. Blute ML, Bergstralh EJ, Iocca A, Scherer B, Zincke H. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol. 2001; 165:119–25.
crossref
6. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, et al. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol. 2000; 163:1171–7.
crossref
7. Hong JH, Lee HM, Choi HY. The predictors of biochemical recurrence and metastasis following radical perineal prostatectomy in clinically localized prostate cancer. Korean J Urol. 2005; 46:1161–7.
8. Cho KS, Hong SJ, Chung BH. The impact of positive surgical margins on biochemical recurrence after radical retropubic prostatectomy. Korean J Urol. 2004; 45:416–22.
9. Kim JB, Kim CS, Park JY. The impact of positive surgical margins and their preoperative predicting factors on biochemical failure after radical retropubic prostatectomy. Korean J Urol. 2003; 44:1262–8.
10. Epstein JI. Pathologic assessment of the surgical specimen. Urol Clin North Am. 2001; 28:567–94.
crossref
11. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Longterm biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am. 2001; 28:555–65.
12. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA. 1997; 277:1452–5.
crossref
13. Shah O, Robbins DA, Melamed J, Lepor H. The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy. J Urol. 2003; 169:2147–52.
crossref
14. Lepor H, Chan S, Melamed J. The role of bladder neck biopsy in men undergoing radical retropubic prostatectomy with preservation of the bladder neck. J Urol. 1998; 160:2435–9.
crossref
15. Cangiano TG, Litwin MS, Naitoh J, Dorey F, deKernion JB. Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy. J Urol. 1999; 162:655–8.
16. Goharderakhshan RZ, Sudilovsky D, Carroll LA, Grossfeld GD, Marn R, Carroll PR. Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. Urology. 2002; 59:709–14.
crossref
17. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst. 2007; 99:1171–7.
crossref
18. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol. 2002; 167:528–34.
crossref
19. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999; 17:1499–507.
crossref
20. Eastham JA, Kattan MW, Riedel E, Begg CB, Wheeler TM, Gerigk C, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol. 2003; 170:2292–5.
crossref
21. Pettus JA, Weight CJ, Thompson CJ, Middleton RG, Stephenson RA. Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location. J Urol. 2004; 172:129–32.
crossref
22. Blute ML, Bostwick DG, Bergstralh EJ, Slezak JM, Martin SK, Amling CL, et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology. 1997; 50:733–9.
crossref
23. Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 1995; 154:1818–24.
crossref
24. Wieder JA, Soloway MS. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol. 1998; 160:299–315.
crossref
25. Tsuboi T, Ohori M, Kuroiwa K, Reuter VE, Kattan MW, Eastham JA, et al. Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins? Urology. 2005; 66:1287–91.
crossref
26. Freeland SJ, Isaacs WB, Platz EA, Terris MK, Aronson WJ, Amling CL, et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol. 2005; 23:7546–54.
27. Hong SK, Yu JH, Han BK, Chang IH, Jeong SJ, Byun SS, et al. Association of prostate size and tumor grade in Korean men with clinically localized prostate cancer. Urology. 2007; 70:91–5.
crossref

Fig. 1.
ROC curve and AUC of serum PSA predicting a positive frozen section at the bladder neck. ROC: receiver operation characteristic, AUC: area under the curve, PSA: prostate-specific antigen.
kju-50-751f1.tif
Table 1.
Preoperative characteristics and results of frozen sections
Variables Mean±SD or number
Mean age (years) 63.5±6.6
Mean PSA (ng/ml) 12.3±11.3
Mean prostate volume (cc) 33.3±11.6
Biopsy Gleason score (%)  
 2-6 171 (47.0)
 7 121 (33.2)
 8-10 72 (19.8)
Mean No. of positive cores 2.7±1.8
Clinical stage (%)  
 T1 235 (64.6)
 T2 or higher 129 (35.4)
Frozen section results (%)  
 Resection margin (+) 90 (24.8)
  Urethra 56 (15.4)
  Bladder neck 45 (12.4)
  Both 11 (3.0)
 Resection margin (−) 274 (75.2)

SD: standard deviation, PSA: prostate-specific antigen

Table 2.
Comparative analysis of preoperative variables between subjects according to the results of frozen sections
Variables Resection margin (−) Resection margin (+)
Total p-value Urethra p-value Bladder neck p-value
No. of patients 274 90   56   45  
Mean PSA (ng/ml)a 10.7±9.4 18.0±16.5 0.001 17.1±16.5 0.013 19.1±15.5 0.002
Mean prostate volume (cc)a 34.4±19.1 27.5±7.3 0.001 27.3±7.3 0.002 26.8±5.2 0.005
Biopsy Gleason score (%)b     0.001   0.006   0.001
 2-6 128 (46.7) 18 (20.0)   11 (19.7)   7 (15.6)  
 7 92 (33.6) 43 (47.8)   27 (48.2)   18 (40.0)  
 8-10 54 (19.7) 29 (32.2)   18 (32.1)   20 (44.4)  
Mean No. of positive coresa 2.7±1.8 2.9±1.7 0.335 2.8±1.7 0.611 3.3±2.4 0.215
Mean % positive cores/total coresa 30.1±19.8 32.2±20.4 0.482 31.1±18.7 0.249 36.7±22.7 0.478
Clinical stage (%)b     0.240   0.226   0.470
 T1 188 (68.6) 47 (52.2)   25 (50)   27 (60)  
 T2 or higher 86 (31.4) 43 (47.8)   25 (50)   18 (40)  
Surgeon's experienceb     0.389   0.241   0.441
 Prior to 250 RP 185 (74.3) 64 (25.7)   34 (13.7)   27 (10.8)  
 250 RP and thereafter 89 (77.4) 26 (22.6)   22 (19.1)   18 (15.7)  

PSA: prostate-specific antigen, RP: radical prostatectomy

a PSA, prostate volume, No. of positive cores and % positive cores/total cores were analyzed as continuous variables

b biopsy Gleason score, clinical stage and surgeon's experience was analyzed as categorical variables

Table 3.
Predictors of a positive frozen section among preoperative variables in binary logistic analysis
  Total Urethra Bladder neck
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value Oddsratio (95% CI) p-value
PSAa Biopsy Gleason scoreb 1.040 (1.005-1.077) 0.027 1.033 (0.996-1.071) 0.079 1.059 (1.002-1.118) 0.041
 2-6            
 7 1.566 (0.639-3.837) 0.308 2.055 (0.709-5.958) 0.347 0.910 (0.245-3.373) 0.552
 8-10 0.844 (0.319-2.232) 0.372 1.313 (0.420-4.102) 0.459 0.449 (0.095-2.132) 0.256
Prostate volumea 0.976 (0.952-1.001) 0.064 0.983 (0.959-1.008) 0.186 0.950 (0.892-1.012) 0.110

CI: confidence interval, PSA: prostate-specific antigen

a PSA and prostate volume were analyzed as continuous variables,

b biopsy Gleason score was analyzed as categorical variables

TOOLS
Similar articles